Abingdon Health Plc
OTC: ABDXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Christopher William Hand
- Employees
- 113
- Headquarters
- York, United Kingdom
- IPO year
- 2022
- Market cap
- $28.9M
- Website
- https://www.abingdonhealth.com
Loading ABDXF…
Loading profile data…Frequently asked questions about ABDXF
What does Abingdon Health Plc (ABDXF) do?
Abingdon Health Plc is a global enterprise dedicated to the innovation, production, and worldwide distribution of diagnostic technologies. Their diverse product portfolio includes rapid self-diagnostic tools like the AbC-19 Rapid Test for detecting COVID-19 IgG antibodies and the 2019-nCoV Antigen Test for identifying SARS-CoV-2 antigens. They a...
Where does ABDXF trade?
Abingdon Health Plc (ABDXF) trades on the Other OTC.
What sector is ABDXF in?
Abingdon Health Plc (ABDXF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Abingdon Health Plc?
Christopher William Hand is the chief executive officer of Abingdon Health Plc (ABDXF).
Where is Abingdon Health Plc headquartered?
Abingdon Health Plc is headquartered in United Kingdom.
Does ABDXF pay a dividend?
Abingdon Health Plc (ABDXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ABDXF go public?
Abingdon Health Plc (ABDXF) completed its initial public offering in 2022.